3D Bio: 3DBio Therapeutics Gets FDA Rare Paediatric Disease Status For AuriNovo
Biologics and bioprinting company 3DBio Therapeutics has secured rare paediatric disease status from the US Food and Drug Administration (FDA) for its AuriNovo living ear-shaped tissue. AuriNova is an investigational...Read More
Read full article »
3DBio is a regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants.
Read more